Feeds:
Posts
Comments

Posts Tagged ‘statistical deficiencies’

MEDICAL NEWS TODAY: The boom in cancer biomarker investments over the past 25 years has not translated into major clinical success. READ MORE>

The reasons for biomarker failures include problems with study design and interpretation, as well as statistical deficiencies, according to an article in The Journal of the National Cancer Institute.

if the biomarker is affected by a non-cancer disease, its utility for cancer detection may be compromised. For example, the prostate-specific antigen (PSA) biomarker, which is used to detect prostate cancer, is also elevated in benign prostatic hyperplasia.

Read Full Post »